Multigenics Intensive Care without Iron
Natural health product licensed in Canada
- Other names
- Essential Intensive Care Iron Free, Multi Intense, Multi-intense Iron Free, Vita Multi
- Licence holder
- Metagenics Inc.
- NPN or DIN-HM
- 80066274
- Status
- Inactive licence
- Licence date
- 7 January 2016
- Revision date
- 29 May 2019
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 15.48 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine C: up to 900 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 30 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 150 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Chrome: up to 150 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 7.5 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 30 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B12 Source : Méthylcobalamine | 25 mcg | 150 µg |
| Zinc Source : Citrate de zinc | 2.58 mg | 15,480 µg |
| Bioflavonoïdes d'agrumes Source : Bioflavonoïdes d'agrumes Potency : 45 % Hesperidin | 12.5 mg | Not calculated |
| Niacinamide Source : Niacinamide | 50 mg | Not calculated |
| Iode Source : Iodure de potassium | 19 mcg | 114 µg |
| Vitamine C Source : Acide ascorbique | 150 mg | 900,000 µg |
| Mélange de concentré de tocophérols Source : Concentré de tocophérols, mélange Potency : 1.84 mg d-alpha Tocopherol | 36.66 mg | Not calculated |
| Calcium Source : Durapatite | 62.5 mg | 375,000 µg |
| Calcium Source : Citrate de calcium | 62.5 mg | 375,000 µg |
| Magnésium Source : Bisglycinate de magnésium | 31.25 mg | 187,500 µg |
| Magnésium Source : Citrate de magnésium | 31.25 mg | 187,500 µg |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 14.9 mg AT | Not calculated |
| 2-hydroxy-N,N,N-triméthyléthanaminium Source : Bitartrate de choline | 15.625 mg | Not calculated |
| Myo-inositol Source : Inositol | 15 mg | Not calculated |
| Phosphore Source : Durapatite | 10.33 mg | 61,980 µg |
| Potassium Source : Aspartate de potassium | 12.375 mg | 74,250 µg |
| Acide-4-aminobenzoïque Source : Acide para-aminobenzoïque | 6.25 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 5 mg | 30,000 µg |
| Riboflavine Source : Riboflavine | 4.25 mg | 25,500 µg |
| Thiamine Source : Mononitrate de thiamine | 3.75 mg | 22,500 µg |
| 2-(3,4-dihydroxyphényl)-3,5,7-trihydroxychromen-4-one Source : Quercétine | 3.125 mg | Not calculated |
| Niacine Source : Acide nicotinique | 2.5 mg | Not calculated |
| Mélange de caroténoïdes Source : Mixed carotenoids | 731.5 mcg | Not calculated |
| Bêta-carotène Source : Mixed carotenoids | 709.5 mcg | Not calculated |
| Bêta-carotène Source : bêta-carotène | 709.5 mcg | Not calculated |
| Cuivre Source : Citrate de cuivre (II) | 250 mcg | 1,500 µg |
| Manganèse Source : Citrate de manganèse (II) | 0.125 mg | 750 µg |
| Folate Source : L-5 Méthyltétrahydrofolate, sel de calcium | 100 mcg | Not calculated |
| Vitamine A Source : Acétate de vitamine A | 56.25 mcg EAR | Not calculated |
| Sélénium Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 25 mcg | 150 µg |
| Chrome Source : Citrate de chrome(III) | 25 mcg | 150 µg |
| Biotine Source : Biotine | 25 mcg | 150 µg |
| Molybdène Source : Produit de chélation de molybdène (VI) et de protéine végétale hydrolysée (PVH) | 13 mcg | 78 µg |
| Vitamine D Source : Cholécalciférol | 1.25 mcg | 7.5 µg |
| 1-Carboxy-N,N,N-chlorure de triméthylméthanaminium Source : Chlorhydrate de bétaine | 21.875 mg | Not calculated |
Non-medicinal ingredients
dérivé cuivre-sodium de la chlorophylline, Cellulose, Acide stéarique, Croscarmellose de sodium, NA, Dioxyde de silicium, Hydroxypropylcellulose, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 6 Comprimé | 1 Tous les jours |
Uses authorised in Canada
To provide antioxidants and factors for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you are taking any prescription medication, consult a health care practitioner prior to use. If you have peptic ulcer or excess stomach acid, consult a health care practitioner prior to use. If you are taking prescription medication, consult a healthcare practitioner prior to use as citrus bioflavonoids may alter the effectiveness of these medications. Consult a healthcare practitioner prior to use if you are taking sulfonamides. For adult use only.
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient.
Source
Official Health Canada record, licence 80066274
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging